毒蕈碱受体拮抗剂：对肺功能的影响。
Muscarinic receptor antagonists: effects on pulmonary function.
作者信息
Buels Kalmia S, Fryer Allison D
机构信息
Oregon Health and Science University, 3181 SW Sam Jackson Park Road, UHN67, Portland, OR 97239, USA.
出版信息
Handb Exp Pharmacol. 2012(208):317-41. doi: 10.1007/978-3-642-23274-9_14.
Abstract
In healthy lungs, muscarinic receptors control smooth muscle tone, mucus secretion, vasodilation, and inflammation. In chronic obstructive pulmonary disease (COPD) and asthma, cholinergic mechanisms contribute to increased bronchoconstriction and mucus secretion that limit airflow. This chapter reviews neuronal and nonneuronal sources of acetylcholine in the lung and the expression and role of M₁, M₂, and M₃ muscarinic receptor subtypes in lung physiology. It also discusses the evidence for and against the role of parasympathetic nerves in asthma, and the current use and therapeutic potential of muscarinic receptor antagonists in COPD and asthma.
摘要
在健康的肺中，毒蕈碱受体控制平滑肌张力、黏液分泌、血管舒张和炎症。在慢性阻塞性肺疾病（COPD）和哮喘中，胆碱能机制导致支气管收缩增强和黏液分泌增加，从而限制气流。本章回顾了肺中乙酰胆碱的神经元和非神经元来源，以及M₁、M₂和M₃毒蕈碱受体亚型在肺生理学中的表达和作用。它还讨论了支持和反对副交感神经在哮喘中作用的证据，以及毒蕈碱受体拮抗剂在COPD和哮喘中的当前应用和治疗潜力。
相似文献
1
Muscarinic receptor antagonists: effects on pulmonary function.毒蕈碱受体拮抗剂：对肺功能的影响。
Handb Exp Pharmacol. 2012(208):317-41. doi: 10.1007/978-3-642-23274-9_14.
2
Muscarinic receptor signaling in the pathophysiology of asthma and COPD.毒蕈碱受体信号传导在哮喘和慢性阻塞性肺疾病病理生理学中的作用
Respir Res. 2006 May 9;7(1):73. doi: 10.1186/1465-9921-7-73.
3
Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling.乙酰胆碱：除了支气管收缩，在炎症和重塑中发挥作用。
Trends Pharmacol Sci. 2015 Mar;36(3):164-71. doi: 10.1016/j.tips.2014.11.005. Epub 2014 Dec 13.
4
The non-neuronal cholinergic system as novel drug target in the airways.非神经元胆碱能系统作为气道的新型药物靶点。
Life Sci. 2012 Nov 27;91(21-22):1113-8. doi: 10.1016/j.lfs.2012.08.030. Epub 2012 Sep 6.
5
Muscarinic agonists and antagonists: effects on gastrointestinal function.毒蕈碱激动剂和拮抗剂：对胃肠功能的影响。
Handb Exp Pharmacol. 2012(208):343-74. doi: 10.1007/978-3-642-23274-9_15.
6
Muscarinic agonists and antagonists: effects on the urinary bladder.毒蕈碱激动剂和拮抗剂：对膀胱的影响。
Handb Exp Pharmacol. 2012(208):375-400. doi: 10.1007/978-3-642-23274-9_16.
7
Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD.毒蕈碱型乙酰胆碱受体在气道炎症和重塑中的调节作用：抗胆碱能治疗哮喘和 COPD 的前景。
Life Sci. 2012 Nov 27;91(21-22):1126-33. doi: 10.1016/j.lfs.2012.02.021. Epub 2012 Mar 3.
8
Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target.气道间质细胞上的毒蕈碱受体：古老靶标的新发现。
Pulm Pharmacol Ther. 2013 Feb;26(1):145-55. doi: 10.1016/j.pupt.2012.07.003. Epub 2012 Jul 25.
9
Muscarinic receptor agonists and antagonists: effects on cardiovascular function.毒蕈碱受体激动剂和拮抗剂：对心血管功能的影响。
Handb Exp Pharmacol. 2012(208):299-316. doi: 10.1007/978-3-642-23274-9_13.
10
Muscarinic receptor agonists and antagonists: effects on ocular function.毒蕈碱受体激动剂和拮抗剂：对眼功能的影响。
Handb Exp Pharmacol. 2012(208):263-98. doi: 10.1007/978-3-642-23274-9_12.
引用本文的文献
1
Steady Quiet Asthma Without Biologics: One-Year Outcomes of Single-Inhaler Triple Therapy for Severe Asthma with Small Airway Dysfunction.未使用生物制剂的稳定型静息性哮喘：单吸入器三联疗法治疗伴有小气道功能障碍的重度哮喘的一年结局
J Clin Med. 2025 Aug 7;14(15):5602. doi: 10.3390/jcm14155602.
2
Too Much SAMA, Too Many Exacerbations: A Call for Caution in Asthma.过多的短效抗胆碱能药物，过多的急性加重：哮喘治疗需谨慎呼吁
J Clin Med. 2025 Jul 16;14(14):5046. doi: 10.3390/jcm14145046.
3
The therapeutic potential of glucagon-like peptide-1 receptor analogs for neuroinflammation in the setting of asthma.胰高血糖素样肽-1受体类似物在哮喘背景下对神经炎症的治疗潜力。
Explor Asthma Allergy. 2025;3. doi: 10.37349/eaa.2025.100967. Epub 2024 Dec 17.
4
A Narrative Review on Higenamine: Pharmacological Properties and Clinical Applications.关于去甲乌药碱的叙述性综述：药理特性与临床应用
Nutrients. 2025 Mar 14;17(6):1030. doi: 10.3390/nu17061030.
5
Single inhaler with beclometasone, formoterol, and glycopyrronium versus triple therapies in adults with uncontrolled asthma: a systematic review and meta-analysis.布地奈德、福莫特罗和格隆溴铵单吸入器与三联疗法治疗成人哮喘控制不佳的系统评价和荟萃分析
Sci Rep. 2025 Feb 4;15(1):4191. doi: 10.1038/s41598-025-88374-w.
6
Update on the Role of β2AR and TRPV1 in Respiratory Diseases.β2AR 和 TRPV1 在呼吸疾病中的作用研究进展。
Int J Mol Sci. 2024 Sep 24;25(19):10234. doi: 10.3390/ijms251910234.
7
Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the "Silent Zone" to Achieving "Quiet Asthma".重度哮喘患者小气道疾病的管理：从“沉默区”向实现“安静哮喘”转变
J Clin Med. 2024 Apr 17;13(8):2320. doi: 10.3390/jcm13082320.
8
First Exploration of the Altered Microbial Gut-Lung Axis in the Pathogenesis of Human Refractory Chronic Cough.初探人类难治性慢性咳嗽发病机制中的微生物肠道-肺部轴改变。
Lung. 2024 Apr;202(2):107-118. doi: 10.1007/s00408-024-00681-7. Epub 2024 Mar 25.
9
An ex vivo rat trachea model reveals abnormal airway physiology and a gland secretion defect in cystic fibrosis.一种离体大鼠气管模型揭示了囊性纤维化中的气道生理异常和腺体分泌缺陷。
PLoS One. 2023 Oct 24;18(10):e0293367. doi: 10.1371/journal.pone.0293367. eCollection 2023.
10
COPD and glycopyrronium responsiveness assessment: An appraisal.慢性阻塞性肺疾病与格隆溴铵反应性评估：一项评估。
Lung India. 2023 May-Jun;40(3):227-234. doi: 10.4103/lungindia.lungindia_376_22.
本文引用的文献
1
Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption.溴化异丙托品作为一种治疗慢性阻塞性肺病的药物，在人支气管上皮细胞中通过有机阳离子/肉碱转运体进行转运：对载体介导的肺部吸收的影响。
Mol Pharm. 2010 Feb 1;7(1):187-95. doi: 10.1021/mp900206j.
2
Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle.膜去极化导致G蛋白偶联受体直接激活，进而引起平滑肌局部钙离子释放。
Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11418-23. doi: 10.1073/pnas.0813307106. Epub 2009 Jun 19.
3
Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.长效毒蕈碱拮抗剂的临床前评估：噻托溴铵与研究药物的比较。
J Pharmacol Exp Ther. 2009 Aug;330(2):660-8. doi: 10.1124/jpet.109.152470. Epub 2009 May 28.
4
Muscarinic receptor subtypes in cilia-driven transport and airway epithelial development.纤毛驱动转运和气道上皮发育中的毒蕈碱受体亚型
Eur Respir J. 2009 May;33(5):1113-21. doi: 10.1183/09031936.00015108. Epub 2009 Feb 12.
5
Etanercept prevents airway hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs.依那西普通过保护抗原激发的豚鼠体内的神经元M2毒蕈碱受体来预防气道高反应性。
Br J Pharmacol. 2009 Jan;156(1):201-10. doi: 10.1111/j.1476-5381.2008.00045.x.
6
Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice.基于毒蕈碱型乙酰胆碱受体基因缺陷小鼠组织切片评估毒蕈碱型乙酰胆碱受体抗体用于免疫组织化学的适用性。
Naunyn Schmiedebergs Arch Pharmacol. 2009 Apr;379(4):389-95. doi: 10.1007/s00210-008-0365-9. Epub 2008 Oct 31.
7
A 4-year trial of tiotropium in chronic obstructive pulmonary disease.噻托溴铵用于慢性阻塞性肺疾病的4年试验。
N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.
8
Lack of specificity of commercially available antisera: better specifications needed.市售抗血清缺乏特异性：需要更好的规格说明。
J Histochem Cytochem. 2008 Dec;56(12):1099-111. doi: 10.1369/jhc.2008.952101. Epub 2008 Sep 15.
9
Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype.噻托溴铵对非嗜酸性粒细胞型重度哮喘有效。
Eur Respir J. 2008 Jun;31(6):1379-80. doi: 10.1183/09031936.00014108.
10
Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts.毒蕈碱受体介导人肺成纤维细胞中胶原蛋白合成的刺激。
Eur Respir J. 2008 Sep;32(3):555-62. doi: 10.1183/09031936.00129307. Epub 2008 May 14.
Zotero 插件